⚠️ Disclaimer As of my last update (June 2024), Wainua is not an approved or widely documented pharmaceutical product. Consequently, no peer‑reviewed pharmacologic data are publicly available. The following outline is…
Vyvanse Vyvanse (lisdexamfetamine dimesylate) is a central nervous system stimulant approved for attention‑deficit/hyperactivity disorder (ADHD) and binge‑eating disorder (BED). It is a dextro‑amphetamine prodrug that offers a predictable, extended‑release profile…
Vyndamax Mechanism of Action Dasatinib (Vyndamax) is a second‑generation tyrosine kinase inhibitor that targets the BCR‑ABL1 fusion protein and Src family kinases. It binds directly to the ATP‑binding pocket of…
Vyepti > Note: As of the current knowledge cut‑off (January 2026), Vyepti is not a commercially available or FDA‑approved drug. Published literature contains no peer‑reviewed pharmacology or clinical‑use data for a…
Vraylar Vraylar (cariprazine) is a second‑generation antipsychotic indicated for the treatment of schizophrenia and bipolar I disorder (manic episodes). It is distinguished by its high affinity for dopamine D3 receptors…
Voydeya Voydeya (dapivirine vaginal gel 0.5 % w/w) – a topical antiretroviral for HIV‑1 pre‑exposure prophylaxis (PrEP) in women. Mechanism of Action Non‑nucleoside reverse transcriptase inhibitor (NNRTI) Binds to the allosteric…
Votrient Votrient (MK‑8776) is an oral, small‑molecule, selective inhibitor of protein kinase B (AKT). It is studied primarily for hematologic malignancies and solid tumors with aberrant AKT signaling. Mechanism of…
Vosevi Vosevi is the first intranasal corticosteroid indicated for the management of chronic rhinosinusitis (CRS) without nasal polyps and for nasal allergy in adults and adolescents ≥12 y. Mechanism of Action…
Vortioxetine Vortioxetine (brand name Luvoxix in some markets, generic vortioxetine) is a multimodal serotonin‑modulating antidepressant approved for major depressive disorder (MDD). Mechanism of Action Primary action: Selective serotonin reuptake inhibitor…
Voriconazole Voriconazole is a second‑generation triazole antifungal used for invasive fungal infections, particularly those caused by Aspergillus spp. and resistant Candida spp. It achieves high intralesional concentrations and is available…